Ashish Life Science Competitors and Similar CompaniesClear all
Ashish Life Science's competitors and similar companies include MicroSintesis, Autolus, Cynata Therapeutics and Longeveron.
 Autolus Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products. |  Cynata Therapeutics Cynata Therapeutics is a stem cell and regenerative medicine company focused on the development of therapies based on Cymerus, a proprietary therapeutic stem cell platform technology. |  Longeveron Longeveron is a life-sciences company developing biological solutions for aging and aging-associated diseases. | |||
Founding Date | Founding Date 1975 | Founding Date 2011 | Founding Date 2014 | Founding Date 2011 | Founding Date 2014 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Mumbai, IN HQ Mumbai, IN | Locations Victoria, CA HQ | Locations London, GB HQ London, GB | Locations Carlton, AU HQ Cremorne, AU Hawthorn, AU | Locations Miami, US HQ |
Employees | Employees 2132% decrease | Employees 8 | Employees 647 | Employees N/A | Employees 259% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.2 b | Valuation ($) 33.8 m | Valuation ($) 31.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $75.4m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $1.2m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $86.6m (FY, 2025) | Cost of goods N/A | Cost of goods $396k (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ($10.7m) (FY, 2025) | Gross profit $1.9m (FY, 2025) | Gross profit $803k (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($287.5m) (FY, 2025) | Net income ($9.4m) (FY, 2025) | Net income ($22.7m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 6.3m (over 7 years ago) | Latest funding round $ 16.4m (almost 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 6.3m | Total funding raised $ 16.4m | Total funding raised $ 281.7m | Total funding raised $ 14.1m | Total funding raised $ 9m |
For sources of this data, please see the company profile
View Company Profiles
MicroSintesis
HQ
Victoria, CA
Employees
8
Microsintesis is an animal health company providing proteobiotics for gut health.
View companyAutolus
HQ
London, GB
Employees
647
Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products.
View companyCynata Therapeutics
HQ
Carlton, AU
Cynata Therapeutics is a stem cell and regenerative medicine company focused on the development of therapies based on Cymerus, a proprietary therapeutic stem cell platform technology.
View companyLongeveron
HQ
Miami, US
Employees
25↑ 9% increase
Longeveron is a life-sciences company developing biological solutions for aging and aging-associated diseases.
View company